Reuters logo
BRIEF-OncoTherapy Science says initiation of Phase I clinical study for OTS167 in patients with breast cancer including Triple-Negative Breast Cancer
May 29, 2017 / 2:53 AM / 4 months ago

BRIEF-OncoTherapy Science says initiation of Phase I clinical study for OTS167 in patients with breast cancer including Triple-Negative Breast Cancer

May 29(Reuters) - OncoTherapy Science Inc

* Says it starts the clinical trial for a Phase I clinical study of OTS167 in patients with breast cancer including Triple-Negative Breast Cancer

Source text in Japanese: goo.gl/OGW221

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below